Nordstrom (JWN) PT Lowered to $40 at Nomura/Instinet Following 1Q

Go back to Nordstrom (JWN) PT Lowered to $40 at Nomura/Instinet Following 1Q

Nordstrom (JWN) Declares $0.37 Quarterly Dividend; 4.4% Yield

May 23, 2019 5:03 PM EDT

Nordstrom (NYSE: JWN) declared a quarterly dividend of $0.37 per share, or $1.48 annualized.

The dividend will be payable on June 18, 2019, to stockholders of record on June 3, 2019, with an ex-dividend date of May 31, 2019.

The annual yield on the dividend is 4.4 percent.

For a... More

Nordstrom (JWN) PT Lowered to $32 at BofA/Merrill Lynch

May 22, 2019 6:46 AM EDT

BofA/Merrill Lynch analyst Lorraine Hutchinson lowered the price target on Nordstrom (NYSE: JWN) to $32.00 (from $40.00) while maintaining a Underperform rating.

... More

Nordstrom (JWN) PT Lowered to $35 at Wedbush

May 22, 2019 6:39 AM EDT

Wedbush analyst Jen Redding lowered the price target on Nordstrom (NYSE: JWN) to $35.00 (from $40.00) while maintaining a Neutral rating.

... More

Nordstrom (JWN) PT Lowered to $36 at Deutsche Bank

May 22, 2019 6:06 AM EDT

Deutsche Bank analyst Paul Trussell lowered the price target on Nordstrom (NYSE: JWN) to $36.00 (from $47.00) while maintaining a Hold rating.

... More

Nordstrom (JWN) PT Lowered to $32 at Gordon Haskett

May 22, 2019 5:54 AM EDT

Gordon Haskett analyst Chuck Grom lowered the price target on Nordstrom (NYSE: JWN) to $32.00 while maintaining a Reduce rating.

Remains negative noting full line issues persist.... More

Nordstrom (JWN) PT Lowered to $33 at Piper Jaffray

May 22, 2019 4:03 AM EDT

Piper Jaffray analyst Erinn Murphy lowered the price target on Nordstrom (NYSE: JWN) to $33.00 (from $40.00) while maintaining a Neutral rating.

... More

After-Hours Movers 05/21: (PVH) (LGF-A) Higher; (TOCA) (EKSO) (LIQT) (more...)

May 21, 2019 5:50 PM EDT

Today's After-Hours Movers

Tocagen Inc. (Nasdaq: TOCA) 25.7% LOWER; announced the Toca 5 Phase 3 clinical trial evaluating Toca 511 & Toca FC in patients with recurrent high grade glioma (HGG) continues without modification following a planned interim analysis of data conducted by an Independent Data Monitoring Committee (IDMC). The IDMC completed its analysis and recommended the trial continue without modification. The global trial enrolled patients across two periods of time and completed full enrollment of 403 patients in November 2018.

Ekso Bionics Holdings, Inc. (Nasdaq:... More

Nordstrom (JWN) Misses Q1 EPS by 20c, Cuts FY EPS Outlook

May 21, 2019 4:06 PM EDT

(Updated - May 21, 2019 4:08 PM EDT)

Nordstrom (NYSE: JWN) reported Q1 EPS of $0.23, $0.20 worse than the analyst estimate of $0.43. Revenue for the quarter came in at $3.44 billion versus the consensus estimate of $3.57... More

Stocks with Implied Volatility Movement

May 21, 2019 4:43 AM EDT

Nordstrom (NYSE: JWN) volatility index movement increasing vs. 30D HV

... More